These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19454611)

  • 1. Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.
    Beeghly-Fadiel A; Lu W; Long JR; Shu XO; Zheng Y; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1770-6. PubMed ID: 19454611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of Matrix Metalloproteinase-2 Promoter Genotypes on Breast Cancer Risk.
    Hung CC; Tsai CL; Chin YT; Wang YC; Liu CH; Lin ML; Chen SS; He JL; Tsai CW; Su CH; Bau DT; Chang WS
    Cancer Genomics Proteomics; 2024; 21(5):502-510. PubMed ID: 39191502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-2 gene polymorphisms are associated with type A aortic dissection and aortic diameters in patients.
    Liu O; Xie W; Qin Y; Jia L; Zhang J; Xin Y; Guan X; Li H; Gong M; Liu Y; Wang X; Li J; Lan F; Zhang H
    Medicine (Baltimore); 2016 Oct; 95(42):e5175. PubMed ID: 27759651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
    Rahimi Z; Yari K; Rahimi Z
    Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.
    Beeghly-Fadiel A; Lu W; Shu XO; Long J; Cai Q; Xiang Y; Gao YT; Zheng W
    Breast Cancer Res Treat; 2011 Apr; 126(2):507-13. PubMed ID: 20725776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women.
    Habel AF; Ghali RM; Bouaziz H; Daldoul A; Hadj-Ahmed M; Mokrani A; Zaied S; Hechiche M; Rahal K; Yacoubi-Loueslati B; Almawi WY
    Tumour Biol; 2019 Apr; 41(4):1010428319845749. PubMed ID: 31014197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of polymorphisms in promoter region of MMP2 and MMP9 with recurrent spontaneous abortion risk in Chinese population.
    Li L; Liu J; Qin S; Li R
    Medicine (Baltimore); 2018 Oct; 97(40):e12561. PubMed ID: 30290617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
    Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of matrix metalloproteinase-2 and -9 promoter polymorphisms with colorectal cancer in Chinese.
    Xu E; Xia X; Lü B; Xing X; Huang Q; Ma Y; Wang W; Lai M
    Mol Carcinog; 2007 Nov; 46(11):924-9. PubMed ID: 17546628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinase-2 Polymorphisms in Chronic Heart Failure: Relationship with Susceptibility and Long-Term Survival.
    Beber AR; Polina ER; Biolo A; Santos BL; Gomes DC; La Porta VL; Olsen V; Clausell N; Rohde LE; Santos KG
    PLoS One; 2016; 11(8):e0161666. PubMed ID: 27551966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
    Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphisms in STK15 and MMP-2 associated susceptibility to esophageal cancer in Mongolian population].
    Chen XB; Chen GL; Liu JN; Yang JZ; Yu DK; Lin DX; Tan W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):559-64. PubMed ID: 19954064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of interleukin-18 gene promoter region polymorphisms and susceptibility to sporadic breast cancer in Chinese Han women.
    Qiao X; Xu D; Sun D; Sun S; Huang Z; Cui W
    J Clin Lab Anal; 2018 Nov; 32(9):e22591. PubMed ID: 29926984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 -735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil.
    Sabbatini AR; Barbaro NR; de Faria AP; Ritter AMV; Modolo R; Correa NB; Brunelli V; Pinho C; Fontana V; Moreno H
    Gene; 2017 Jul; 620():23-29. PubMed ID: 28390988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women.
    Chan KY; Liu W; Long JR; Yip SP; Chan SY; Shu XO; Chua DT; Cheung AN; Ching JC; Cai H; Au GK; Chan M; Foo W; Ngan HY; Gao YT; Ngan ES; Garcia-Barceló MM; Zheng W; Khoo US
    J Med Genet; 2009 Jan; 46(1):32-9. PubMed ID: 18782836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
    Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of
    Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
    In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.
    Kang H; Dai Z; Ma X; Ma L; Jin Y; Liu X; Wang X
    Gene; 2013 Nov; 531(1):97-100. PubMed ID: 23994194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.